Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingred...
Lifeon Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 121 million yuan, a year-on-year increase of 1.65%
A-share innovative drug concept stocks fluctuated lower, with InventisBio falling over 10%. Other stocks such as Huahai Pharmaceutical, JENKEM, Lifeon Pharmaceutical, JOINN, Guangsheng Tang, HitGen, and Baillie Gifford also dropped more than 6%
Lifeon Pharmaceutical: Gao Meihua reduced her stake by 0.16%
Ophthalmology medical concept stocks surged, SPAS hit the daily limit in the afternoon
Lifeon Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 90.2271 million yuan, an increase of 16.53%
The chemical pharmaceutical sector fluctuated and weakened, with TIBET AIM PHARM hitting the limit down, followed by Lifeon Pharmaceutical, JLPC, huahaipharm, Foyou Pharma, and CHENGYIPHARMA